使用特定药理学制剂如抗氧化剂和PKC抑制剂，靶向血管内皮生长因子表达可能证明对治疗糖尿病性视网膜病变是有效的。
Targeting VEGF expression with specific pharmacological agents, such as antioxidants and PKC inhibitors, may prove efficacious for the treatment of diabetic retinopathy.
目的利用包裹阿霉素的血管内皮生长因子（VEGF）脂质体于体外靶向杀伤肿瘤血管内皮细胞。
ObjectiveTo evaluate the targeting ability and cytotoxicity of adriamycin liposomes conjugated with VEGF in vitro.
随着分子生物学研究的进展，表皮生长因子受体抑制剂、血管内皮生长因子抑制剂等分子靶向药物的研究成为热点之一。
With the advancement of the study of molecular biology, the research of the molecular targeted drugs such as EGFR inhibitor and VEGF inhibitor, become one of the hot spots.
随着分子生物学研究的进展，表皮生长因子受体抑制剂、血管内皮生长因子抑制剂等分子靶向药物的研究成为热点之一。
With the advancement of the study of molecular biology, the research of the molecular targeted drugs such as EGFR inhibitor and VEGF inhibitor, become one of the hot spots.
应用推荐